AP Biosciences Inc (6945.TWO)
TWD 42.0
(6.06%)
TWD 42.0
(6.06%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 890.75 Million TWD | -19.26% |
| 2022 | 1.1 Billion TWD | 90.42% |
| 2021 | 579.34 Million TWD | 88753.32% |
| 2020 | 652.02 Thousand TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.88 Billion TWD | 0.0% |
| 2024 Q1 | 1.88 Billion TWD | 112.15% |
| 2023 Q4 | 890.75 Million TWD | 0.0% |
| 2023 FY | 890.75 Million TWD | -19.26% |
| 2023 Q3 | 890.75 Million TWD | -18.95% |
| 2023 Q2 | 1.09 Billion TWD | 0.0% |
| 2023 Q1 | 1.09 Billion TWD | -0.37% |
| 2022 Q4 | 1.1 Billion TWD | 0.0% |
| 2022 Q3 | 1.1 Billion TWD | 0.0% |
| 2022 FY | 1.1 Billion TWD | 90.42% |
| 2021 FY | 579.34 Million TWD | 88753.32% |
| 2020 FY | 652.02 Thousand TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 69.294% |
| Level Biotechnology Inc. | 822.67 Million TWD | -8.276% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -34.004% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -62.325% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 77.124% |
| GlycoNex Incorporation | 1.55 Billion TWD | 42.636% |
| VBI | 452.1 Million TWD | -97.025% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 24.265% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -18.994% |
| Visgeneer Inc. | 397.17 Million TWD | -124.272% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 76.375% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 58.743% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -0.868% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 85.38% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1110.957% |
| Enimmune corporation | 604.82 Million TWD | -47.275% |
| TaiRx, Inc. | 833.74 Million TWD | -6.838% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 71.136% |
| EirGenix Inc. | 11.16 Billion TWD | 92.02% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -55.417% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 47.981% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 75.234% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 15.205% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -195.901% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -236.57% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -101.898% |
| RBC Bioscience Corporation | 753.79 Million TWD | -18.17% |
| BiOptic Inc. | 613.77 Million TWD | -45.128% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 49.92% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 23.192% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -38.134% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 71.324% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -595.648% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -135.424% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 21.439% |
| Neith Corporation | 192.15 Million TWD | -363.566% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -502.131% |
| NaviFUS Corp. | 490.53 Million TWD | -81.589% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 27.328% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 34.665% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -68.338% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 23.302% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 46.219% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 89.554% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -174.799% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 33.209% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 67.144% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 94.202% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -117.121% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -124.456% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 57.091% |
| TCI GENE Inc. | 1.16 Billion TWD | 23.602% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -202.381% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 34.663% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 5.416% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -27.533% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 77.472% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 76.698% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 27.571% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 84.105% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 16.125% |
| Acepodia, Inc. | 6.81 Billion TWD | 86.936% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 76.721% |